Ventas 2025-26: SHOP NOI +15% (4th Consecutive DD Year)
FY25 revenue $5.83B (+18%); Op income $827M (+21%); NI $251M (+210%); EPS $0.54. Normalized FFO/share +9%. Same-store SHOP cash NOI +15% (4th consecutive year of double-digit growth). Q4 SHOP revenue +8%, NOI +15.4%, margin +180bp to 28%+. Average occupancy +280bp FY25. FY26 guide: normalized FFO/share $3.78-$3.88 midpoint $3.83 (+8%), SHOP same-store cash NOI +13-17%, total same-store cash NOI ~10%, $2.5B investment.
Key takeaways
- 4th consecutive year of double-digit SHOP NOI growth. Q4 SHOP same-store cash NOI +15.4%; FY full year +15%. Aging demographic + Ventas operational platform driving sustained outperformance.
- Normalized FFO/share +9% FY25 to ~$3.55. Strong operating leverage as SHOP scale + occupancy + pricing all compound.
- Q4 occupancy +280bp YoY. Sustained occupancy gains driving NOI growth. US senior housing market still under-penetrated relative to demographic demand.
- FY26 guide: FFO/share $3.78-$3.88 (+8% YoY midpoint). SHOP same-store cash NOI +13-17%; total same-store cash NOI ~10%; $2.5B investment in property + adjacencies.
- 1-2-3 Strategy emphasized. Senior housing leveraging secular demand from aging population + proprietary Ventas operational insights + financial strength + industry relationships.
Business
Ventas is one of the largest US healthcare-focused REITs, owning ~1,200 senior housing + medical office + life science + skilled nursing properties. Three reporting segments:
- Senior Housing Operations Platform (SHOP) (~50% of revenue, growing fastest): Operated senior housing communities (assisted living, memory care, independent living). Ventas operates with Atria + Sunrise + others as managers; recognizes property NOI directly. Q4 SHOP revenue +8%, NOI +15.4%, margin +180bp to 28%+.
- Outpatient Medical & Research (~30% of revenue): Medical office buildings + research/lab space. Steady cash flow, lower growth.
- Triple-Net Leased Properties (~20% of revenue): Senior housing + skilled nursing + specialty hospitals leased to operators (not operated by Ventas). Lower growth, more stable.
Strategic positioning: largest pure-play senior housing investor with operational platform vs Welltower's hybrid model. SHOP segment scales with operating performance; aging demographics provide multi-decade tailwind.
FY25 financial performance
| Metric (FY) | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue ($B) | 4.50 | 4.92 | 5.83 |
| Op income ($M) | 416 | 681 | 827 |
| EBITDA ($B) | 1.95 | 1.94 | 2.24 |
| Net income ($M) | -41 | 81 | 251 |
| Diluted EPS ($) | -0.10 | 0.19 | 0.54 |
| Normalized FFO/share | ~$2.95 | ~$3.20 | ~$3.55 |
| FCF ($B) | 0.94 | 1.06 | 1.32 |
| Capex ($M) | -259 | -282 | -364 |
| Total debt ($B) | 13.69 | 13.74 | 13.22 |
| Dividends ($M) | -724 | -740 | -860 |
The earnings print: Revenue +18% on SHOP scale + occupancy + pricing; op income +21%; net income +210% on revenue + margin expansion. Normalized FFO/share +9%.
Capital allocation
- Capex: $-364M FY25 (6.2% of revenue) for property maintenance + improvements.
- Dividends: $-860M FY25 (+16% YoY). Continued raise.
- Buybacks: zero. Capital priority on investment + debt management.
- Investment: ~$1B+ FY25 acquisitions; FY26 plan $2.5B.
- Debt: $13.22B (-$0.52B YoY).
FY26 outlook (per Q4 2025 call, 2026-02-06)
| FY26 guide | Range / point |
|---|---|
| Normalized FFO per share | $3.78-$3.88 (midpoint $3.83, +8%) |
| SHOP same-store cash NOI growth | +13% to +17% |
| Total same-store cash NOI growth | ~10% |
| Investment plan | $2.5B |
| 1-2-3 Strategy | Continued execution |
The +13-17% SHOP same-store cash NOI guide is the structural read — fourth consecutive year of double-digit, with mgmt seeing continued runway. Senior housing demographics + occupancy + pricing all favorable.
Key risks
- Senior housing operator performance: Atria + Sunrise + others — Ventas's manager partners. Operator failure or strategic shift.
- Occupancy ceiling: Eventually occupancy maxes out; growth must shift to pricing + new properties.
- Wage / labor cost: Senior housing labor-intensive; staffing + wage cost cycle.
- Interest rates: REIT valuation + refinancing cost both sensitive.
- Healthcare regulation: Medicare + Medicaid + private pay reimbursement dynamics.
- Competition: Welltower + Healthpeak + smaller senior housing REITs all competing.
Bottom line
VTR FY25 is the SHOP-driven cash NOI compounding year — 4th consecutive year of double-digit. Revenue +18%, op income +21%, EPS $0.54 (+184%), normalized FFO/share +9%. FY26 guide FFO/share +8%, SHOP same-store +13-17%, total same-store cash NOI ~10%, $2.5B investment. The structural read: dominant senior housing REIT with multi-decade demographic tailwind + operational platform. Risks are operator partner + occupancy ceiling + interest rates.
Citations
- Ventas Inc. FY25 Form 10-K (filed February 2026, SEC EDGAR).
- Ventas Q4 2025 earnings call, 2026-02-06 — 1-2-3 Strategy emphasis (senior housing demand + operational platform + financial strength + industry relationships); Q4 SHOP revenue +8%, NOI +15.4%, margin +180bp to 28%+, occupancy +280bp; normalized FFO/share +9%; FY full year SHOP same-store cash NOI +15% (4th consecutive year DD); FY26 guide ($3.78-$3.88 normalized FFO/share, SHOP +13-17%, total +10%, $2.5B investment).
- Internal financial_statements view (consolidated annual + cash flow + capital structure).